跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-220
首页
药物
AT-220
AT-220
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pathogenic gene PDGFB of human idopathic basal ganglia calcification (IBGC) and with mutation at site 220, and detection method thereof
申请人: FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIV
优先权: 2017
CN
SYSTEMS AND METHODS FOR TREATING THE NASAL CAVITY
申请人: ARRINEX INC
优先权: 2018
CN
Heat stable keratinase and use thereof
申请人: ACADEMIA SINICA
优先权: 2014
US
Pharmaceutical composition for treating sequelae of pelvic inflammatory disease and preparation method thereof
申请人: SHANDONG ZHONGDA PHARM CO LTD
优先权: 2026
CN
SYNCHRONIZED WATER AND PRODUCTION AND USE THEREOF
申请人: JOHANSSON BENNY
优先权: 2007
US
Coarse cereals flour capable of removing black spot and wrinkle and preparation method thereof
申请人: FAN ZHIQIANG
优先权: 2018
CN
VARIANT FC DOMAINS AND USES THEREOF
申请人: CHIDALA TREAT COMPANIES
优先权: 2019
CN
Plasmon-assisted Pyrolysis for Site-specific Protein Digestion
申请人: BASILE FRANCO
优先权: 2012
US
药物
反馈